“Integrated Network Pharmacology, ADMET Profiling, and Molecular Docking Investigation of Losartan and Its Active Metabolite Against Angiotensin-Related Target”, IJPRMP, vol. 2, no. 5, pp. 76–82, Oct. 2026, doi: 10.61280/4sa10p81.